신장내과김현숙 교수 사진

김현숙

진료과 : 신장내과 홈페이지

전문진료분야 : 상염색체우성다낭신, 기타낭성신질환, 고혈압, 혈뇨, 단백뇨, 신부전, 투석


(주간) 진료시간표 (2020-08-10 ~ 2020-08-15)

* 전화예약 : 033) 240-5000

전화예약(033) 240-5000)
의료진 진료시간표
진료시간
오전       
오후        

학 력

내용 숨기기
·서울대학교 대학원 박사졸업 (2019)
·서울대학교 대학원 석사졸업(2014)
·가톨릭대학교 의과대학 학사졸업(2010-2013)

경 력

내용 숨기기
·춘천성심병원 신장내과 조교수
ㆍ서울대학교병원 신장내과 전임의 (2014-2017)
ㆍ서울대학교병원 내과 전공의 (2013)

가입학회 및 활동

내용 숨기기
ㆍ대한 신장학회 정회원
ㆍ대한 내과학회 정회원
ㆍ미국 신장학회 정회원
ㆍ한국 유전체학회 정회원
ㆍ한국역학회 정회원
ㆍ상염색체 우성 다낭신환우회다낭사랑 자문의 (www.pkdkorea.co.kr)

학술편집 활동

내용 숨기기
ㆍ임상신장학 핸드북 (2017)
ㆍCystogenesis, Springer, (2016)
ㆍ내과메뉴얼, 서울대학교병원 (2013, 2016)

수상경력

내용 숨기기
ㆍ세계인명사전 Marquis Who's Who 등재 (2017-2019)
ㆍ대한신장학회 우수초록상 (2017)
ㆍ대한신장학회 우수포스터상 (2017)
ㆍ대한신장학회 우수연구자상 (2015,2016)
ㆍ서울대학교병원 우수전공의 (2012)

국내학회지 발표논문

내용 숨기기
1. Jo EJ, Yang MS, Kim YJ, Kim HS, Kim MY, Kim SH, et al. Food-dependent exercise-induced anaphylaxis occurred only in a warm but not in a cold environment. Asia Pac Allergy. 2012;2(2):161-4.

2. 고성준, 김현숙, 신나라, 한미연, 김효진, 최홍미, et al. 뇌동맥류결찰술직후발생한중추성요붕증과동반된 SIADH 1 예. 전북의대논문집. 2013;37(2):19-26.

3. Jo HA, Park HC, Kim H, Han M, Jeong JC, Oh K-H, et al. Effect of Simultaneous Nephrectomy on Perioperative Blood Pressure and Graft Outcome in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease. The Journal of the Korean Society for Transplantation. 2016;30(1):24-30.

4. Kim H, Choi GH, Shim KE, Lee JH, Heo NJ, Joo K-W, et al. Changes in bioimpedance analysis components before and after hemodialysis. Kidney research and clinical practice. 2018;37(4):393.

5. Kim H, Yu Y, Shim KE, Kim JE, Koh J, Yoon JW, et al. Esophageal Artery Pseudoaneurysm and Takayasu Arteritis in a Patient with Autosomal Dominant Polycystic Kidney Disease. Electrolyte Blood Press. 2018;16(1):11-4.

국제학회지 발표논문

내용 숨기기
1. Kim H, Park HC, Lee S, Lee J, Cho C, Kim DK, et al. Successfully treated Escherichia coli-induced emphysematous cyst infection with combination of intravenous antibiotics and intracystic antibiotics irrigation in a patient with autosomal dominant polycystic kidney disease. J Korean Med Sci. 2013;28(6):955-8.

2. Kim HJ, Kim H, Cho HS, Hwang JH, Jung IM, Ahn C, et al. Outcomes of kidney allograft in recipients with kidney disease of unknown etiology. Clinical Transplantation. 2013;27(6):866-74.

3. Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, et al. Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study. BMC Nephrol. 2013;14:112.

4. Baek SH, Kim H, Lee J, Kim DK, Oh KH, Kim YS, et al. Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea. Korean J Intern Med. 2014;29(1):40-8.

5. Han M, Park HC, Kim H, Jo HA, Huh H, Jang JY, et al. Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol. 2014;15:63.

6. Kim H, Kim HJ, Shin N, Han M, Park H, Kim M, et al. Visceral obesity is associated with microalbuminuria in nondiabetic Asians. Hypertens Res. 2014;37(7):679-84.

7. Shin N, Kim H, Kim HJ, Han M, Lee S, Jo H, et al. A mild decrease of renal function is related to increased hemoglobin level during 5-year follow-up period. Korean J Intern Med. 2014;29(3):341-51.

8. Kim H, An JN, Kim DK, Kim MH, Kim H, Kim YL, et al. Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study. PloS one. 2015;10(6):e0131393.

9. Kim H, Park HC, Ryu H, Kim K, Kim HS, Oh KH, et al. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease. PloS one. 2015;10(12):e0144526.

10. Park HC, Kang A-Y, Jang JY, Kim H, Han M, Oh K-H, et al. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients. BMC nephrology. 2015;16(1):86.

11. Yang J, Ryu H, Han M, Kim H, Hwang YH, Chung JW, et al. Comparison of volume-reductive therapies for massive polycystic liver disease in autosomal dominant polycystic kidney disease. Hepatology research : the official journal of the Japan Society of Hepatology. 2016;46(2):183-91.

12. Kim H, Hwang YH. Clinical Trials and a View Toward the Future of ADPKD. Adv Exp Med Biol. 2016;933:105-21.

13. Bae EH, Kim H, Kim SS, Ma SK, Kim SW. Focal segmental glomerulosclerosis in atypical polycystic kidney disease. The Korean journal of internal medicine. 2017;32(4):766.

14. Kang E, Han M, Kim H, Park SK, Lee J, Hyun YY, et al. Baseline General Characteristics of the Korean Chronic Kidney Disease: Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci. 2017;32(2):221-30.

15. Ryu H, Kim H, Park HC, Kim H, Cho EJ, Lee K-B, et al. Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease. BMC nephrology. 2017;18(1):22.

16. Kim H, Koh J, Park SK, Oh KH, Kim YH, Kim Y, et al. Baseline characteristics of the autosomal‐dominant polycystic kidney disease sub‐cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease. Nephrology. 2019;24(4):422-9.

17. Ryu H, Park HC, Kim H, Heo J, Kang E, Hwang YH, et al. Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease. PloS one. 2019;14(4):e0214912.

18. Yun S, Han M, Kim HJ, Kim H, Kang E, Kim S, et al. Genetic risk score raises the risk of incidence of chronic kidney disease in Korean general population-based cohort. Clinical and experimental nephrology. 2019:1-9.

19. Kim H, Park HC, Ryu H, Kim H, Lee HS, Heo J, et al. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing. Scientific reports. 2019;9(1):16952.

20. Kim H, Sung J, Kim H, Ryu H, Cho Park H, Oh YK, et al. Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease. BMB reports. 2019;52(7):463-8.

21. Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, et al. Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study. Nephrology (Carlton, Vic). 2019;24(12):1214-24.

22. Kim H, Ryu J, Lee YK, Choi MJ, Cho A, Koo JR, et al. Seropositive rate of the anti-hepatitis A immunoglobulin G antibody in maintenance hemodialysis subjects from two hospitals in Korea. Korean J Intern Med. 2019;34(6):1297-303.

23. Kim H, Oh YK, Park HC, Park S, Lee S, Lee HY, et al. Clinical experience with white blood cell-PET/CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection: A prospective case series. Nephrology (Carlton, Vic). 2018;23(7):661-8.